Seraph Biosciences Overview
- Year Founded
-
2011

- Status
-
Private
- Employees
-
7

- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$7.12M
- Investors
-
1
Seraph Biosciences General Information
Description
Developer of real-time pathogen detection systems designed to treat infections at the point of care. The company represents a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral, and fungal pathogens, enabling healthcare providers to effectively eliminate the need for time-consuming and costly laboratory-based methods of specimen collection, processing, and pathogen identification.
Contact Information
Website
www.seraspec.comCorporate Office
- 1001 Woodward Avenue
- Suite 500
- Detroit, MI 48226
- United States
Corporate Office
- 1001 Woodward Avenue
- Suite 500
- Detroit, MI 48226
- United States
Seraph Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Later Stage VC | 16-Aug-2021 | $7.12M | Completed | Generating Revenue | ||
3. Later Stage VC (Series B) | 03-Jan-2019 | Completed | Startup | |||
2. Later Stage VC (Series A) | 28-May-2017 | $5M | $5.25M | Completed | Startup | |
1. Angel (individual) | 21-Oct-2015 | $250K | $250K | Completed | Startup |
Seraph Biosciences Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series B | ||||||||
Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Seraph Biosciences Patents
Seraph Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
EP-4275035-A1 | Raman-based systems and methods for material identification | Inactive | 05-Jan-2021 | ||
US-20240060899-A1 | Raman-based systems and methods for material identification | Pending | 05-Jan-2021 | ||
ES-2877351-T3 | Micro-raman-based portable detection instrument and detection method | Active | 07-Aug-2013 | ||
EP-3922965-A2 | Hand-held micro-raman based detection instrument and method of detection | Inactive | 07-Aug-2013 | ||
US-11236379-B2 | Raman based detection instrument and method of detection | Active | 07-Aug-2013 | G01J3/18 |
Seraph Biosciences Signals
Seraph Biosciences Investors (1)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Invest Detroit Ventures | Corporate Venture Capital | Minority |
Seraph Biosciences FAQs
-
When was Seraph Biosciences founded?
Seraph Biosciences was founded in 2011.
-
Where is Seraph Biosciences headquartered?
Seraph Biosciences is headquartered in Detroit, MI.
-
What is the size of Seraph Biosciences?
Seraph Biosciences has 7 total employees.
-
What industry is Seraph Biosciences in?
Seraph Biosciences’s primary industry is Monitoring Equipment.
-
Is Seraph Biosciences a private or public company?
Seraph Biosciences is a Private company.
-
What is Seraph Biosciences’s current revenue?
The current revenue for Seraph Biosciences is
. -
How much funding has Seraph Biosciences raised over time?
Seraph Biosciences has raised $16.6M.
-
Who are Seraph Biosciences’s investors?
Invest Detroit Ventures has invested in Seraph Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »